Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XFOR

X4 Pharmaceuticals Inc

Jun 08 • 04:00PM ET

3.71

-0.12 -3.13 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: BMRN INCY KRYS KYMR NUVL RYTM VKTX AXSM MDGL NBIX

| Held by: VTI VXF AVSC PRFZ BTEC URTY ITWO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.54	Insider Own	19.50%	Shs Outstand	94.32M	Perf Week	-9.73%
Market Cap	349.93M	Forward P/E	-	EPS next Y	-0.80	Insider Trans	-0.09%	Shs Float	75.92M	Perf Month	-13.52%
Enterprise Value	193.46M	PEG	-	EPS next Q	-0.18	Inst Own	82.79%	Short Float	3.85%	Perf Quarter	-10.60%
Income	-99.72M	P/S	38.84	EPS this Y	60.96%	Inst Trans	2.84%	Short Ratio	6.91	Perf Half Y	-2.37%
Sales	9.01M	P/B	2.08	EPS next Y	-9.25%	ROA	-49.82%	Short Interest	2.92M	Perf YTD	-7.25%
Book/sh	1.79	P/C	1.50	EPS next 5Y	27.70%	ROE	-104.21%	52W High	4.83 -23.19%	Perf Year	-13.72%
Cash/sh	2.48	P/FCF	-	EPS past 3/5Y	65.48% 54.19%	ROIC	-40.71%	52W Low	1.35 174.81%	Perf 3Y	-94.25%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 63.56%	Gross Margin	79.04%	Volatility	5.91% 6.05%	Perf 5Y	-98.66%
Dividend TTM	-	EV/Sales	21.47	EPS Y/Y TTM	-300.04%	Oper. Margin	-1084.38%	ATR (14)	0.24	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.98	Sales Y/Y TTM	-71.26%	Profit Margin	-1106.30%	RSI (14)	39.28	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.18	EPS Q/Q	-490.02%	SMA20	-7.63%	Beta	0.40	Target Price	11.75
Payout	-	Debt/Eq	0.46	Sales Q/Q	-90.60%	SMA50	-9.76%	Rel Volume	1.07	Prev Close	3.83
Employees	45	LT Debt/Eq	0.45	Earnings	May 06 BMO	SMA200	-1.35%	Avg Volume	423.37K	Price	3.71
IPO	Nov 16, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	20.00% -22.84%	Trades		Volume	451,733	Change	-3.13%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)